Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Aging slows wound healing due to weaker cells and immune response.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

The meeting presented findings on effective treatments for various pet skin conditions and insights into the immune responses of dogs with atopic dermatitis.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Targeting Vδ1+T-cells may help treat alopecia areata.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Skin bacteria can help wound healing by activating certain immune cells.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

BST2 protein and certain T cells increase in early alopecia areata.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.